CRISAFULLI, Ernesto
 Distribuzione geografica
Continente #
NA - Nord America 7.149
EU - Europa 5.007
AS - Asia 3.967
SA - Sud America 656
Continente sconosciuto - Info sul continente non disponibili 367
AF - Africa 100
OC - Oceania 9
Totale 17.255
Nazione #
US - Stati Uniti d'America 6.869
RU - Federazione Russa 2.279
SG - Singapore 1.848
IT - Italia 1.116
CN - Cina 736
BR - Brasile 510
HK - Hong Kong 450
VN - Vietnam 384
FR - Francia 378
IE - Irlanda 311
DE - Germania 263
GB - Regno Unito 162
CA - Canada 131
SE - Svezia 129
KR - Corea 128
BD - Bangladesh 110
NL - Olanda 99
FI - Finlandia 73
IN - India 69
AR - Argentina 68
ID - Indonesia 36
IQ - Iraq 31
JP - Giappone 31
PL - Polonia 31
ES - Italia 30
MX - Messico 29
TR - Turchia 25
BE - Belgio 23
EC - Ecuador 21
GT - Guatemala 21
CR - Costa Rica 20
ZA - Sudafrica 20
BJ - Benin 19
UA - Ucraina 18
NG - Nigeria 17
PK - Pakistan 16
CL - Cile 15
CO - Colombia 15
LT - Lituania 14
PH - Filippine 14
CW - ???statistics.table.value.countryCode.CW??? 13
SA - Arabia Saudita 13
PR - Porto Rico 12
TT - Trinidad e Tobago 12
JM - Giamaica 11
MY - Malesia 11
VE - Venezuela 11
AT - Austria 10
EU - Europa 10
SV - El Salvador 10
TG - Togo 10
UZ - Uzbekistan 10
JO - Giordania 9
NI - Nicaragua 8
AE - Emirati Arabi Uniti 7
HN - Honduras 7
KE - Kenya 7
PY - Paraguay 7
AU - Australia 6
CZ - Repubblica Ceca 6
EE - Estonia 6
MA - Marocco 6
AL - Albania 5
DO - Repubblica Dominicana 5
DZ - Algeria 5
EG - Egitto 5
IL - Israele 5
LV - Lettonia 5
RO - Romania 5
UY - Uruguay 5
BG - Bulgaria 4
BH - Bahrain 4
BY - Bielorussia 4
CH - Svizzera 4
DK - Danimarca 4
HU - Ungheria 4
KZ - Kazakistan 4
LB - Libano 4
NO - Norvegia 4
NP - Nepal 4
PT - Portogallo 4
TN - Tunisia 4
AZ - Azerbaigian 3
BZ - Belize 3
HR - Croazia 3
IR - Iran 3
MT - Malta 3
SI - Slovenia 3
TH - Thailandia 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BB - Barbados 2
BO - Bolivia 2
BS - Bahamas 2
GP - Guadalupe 2
MG - Madagascar 2
NC - Nuova Caledonia 2
PA - Panama 2
RS - Serbia 2
SN - Senegal 2
SY - Repubblica araba siriana 2
Totale 16.892
Città #
Dallas 1.258
Ashburn 1.045
San Jose 898
Singapore 873
Moscow 761
Chandler 476
Hong Kong 447
Council Bluffs 324
Dublin 305
Verona 240
The Dalles 193
Jacksonville 186
Ho Chi Minh City 132
Beijing 120
Princeton 109
Lawrence 108
Los Angeles 108
Sindelfingen 100
New York 91
Seattle 91
Wilmington 85
Hanoi 75
Santa Clara 74
Redondo Beach 70
Rome 65
Buffalo 64
Milan 53
São Paulo 52
Columbus 44
Boardman 41
Munich 39
Frankfurt am Main 37
London 37
Redmond 35
Helsinki 34
Montreal 32
Tokyo 29
Chicago 28
Bologna 27
Warsaw 26
Xi'an 26
Ann Arbor 25
Orem 25
Turku 25
Falkenstein 24
Norwalk 24
Phoenix 24
Southend 24
Denver 23
Haiphong 23
Atlanta 22
Brooklyn 22
Tianjin 21
Turin 21
San Francisco 20
Toronto 20
Amsterdam 19
Cotonou 19
San José 19
Nuremberg 18
Abuja 17
Brussels 17
Chennai 17
Da Nang 17
Guangzhou 17
McKinney 17
Dongguan 16
Rio de Janeiro 16
Guatemala City 15
Paris 15
Houston 14
Jinan 14
Lappeenranta 14
Naples 14
North Bergen 14
Stockholm 14
Poplar 13
Willemstad 13
City of London 12
Falls Church 12
Mexico City 12
Baghdad 11
Brasília 11
Curitiba 11
Kent 11
Washington 11
Ankara 10
Florence 10
Genoa 10
Jakarta 10
Lomé 10
Mumbai 10
Nanjing 10
New Delhi 10
San Salvador 10
Trento 10
Amman 9
Bari 9
Biên Hòa 9
Boston 9
Totale 9.757
Nome #
Polmonite interstiziale con caratteristiche autoimmuni (IPAF) Interstitial pneumonia with autoimmune features (IPAF 740
Glucocorticoid Treatment in Severe COPD Exacerbations: Biological Rationale, Clinical Effects, and Practical Advice 367
Persistence of fatigue in the absence of pathophysiological mechanisms in some patients more than 2 years after the original SARS-CoV-2 infection 302
Role of Non-Invasive Ventilation in Elderly Patients: Therapeutic Opportunity or Medical Futility? An Updated Narrative Review 278
Nervous system: subclinical target of SARS-CoV-2 infection 195
Asthmatic patients in COVID-19 outbreak: Few cases despite many cases 191
Neurological symptoms and axonal damage in COVID-19 survivors: are there sequelae? 189
Chronic fatigue syndrome: an emerging sequela in COVID-19 survivors? 188
Exercise prehabilitation in lung cancer: Getting stronger to recover faster 187
Asthma in a large COVID-19 cohort: Prevalence, features, and determinants of COVID-19 disease severity 186
Serology study after BTN162b2 vaccination in participants previously infected with SARS-CoV-2 in two different waves versus naïve 186
Six-minute walk distance in healthy subjects: reference standards from a general population sample 184
Cytomegalovirus-Induced Gastrointestinal Bleeding and Pancreatitis Complicating Severe Covid-19 Pneumonia: A Paradigmatic Case 172
Acute exacerbations of COPD: Risk factors for failure and relapse 166
Impact of the Visceral Adipose Tissue on Bone Quality in Patients with Untreated mild-to-severe Obstructive Sleep Apnoea 164
Importance of Cardiopulmonary Exercise Testing amongst Subjects Recovering from COVID-19 162
A shadow in the GOLD ABCD classification system: measurement of perception of symptoms in COPD 161
Bone Mineral Density in Mountain, Road Cyclists and Untrained Controls: Exercise, Diet and Hormones 158
COVID-19 in severe asthmatic patients during ongoing treatment with biologicals targeting type 2 inflammation: Results from a multicenter Italian survey 158
A pulmonary infection by Actinomyces odontolyticus and Veillonella atypica in an immunocompetent patient with dental caries 158
Residual Lung Function Impairment Is Associated with Hyperventilation in Patients Recovered from Hospitalised COVID-19: A Cross-Sectional Study 157
Mepolizumab 100 mg in severe asthmatic patients with EGPA in remission phase 148
Impact of sex on circulating leukocytes composition in COPD patients 148
Innate immune reprogramming in circulating neutrophils of COPD patients 146
Efficacy of temporary positive expiratory pressure (TPEP) in patients with lung diseases and chronic mucus hypersecretion. The UNIKO® project: a multicentre randomized controlled trial 142
Aerobic Intermittent Hypoxic Training Is Not Beneficial for Maximal Oxygen Uptake and Performance: A Systematic Review and Meta-Analysis 140
A High Degree of Dyspnea Is Associated With a Poor Maximum Exercise Capacity in Subjects With COPD With the Same Severity of Air-Flow Obstruction 138
Clinical factors associated with death in 3044 COVID-19 patients managed in internal medicine wards in Italy: results from the SIMI-COVID-19 study of the Italian Society of Internal Medicine (SIMI) 138
Metabolic-associated fatty liver disease and liver fibrosis scores as COVID-19 outcome predictors: a machine-learning application 137
Circulating eosinophil levels and lung function decline in stable chronic obstructive pulmonary disease: a retrospective longitudinal study 135
Beyond diagnosis: a narrative review of the evolving therapeutic role of medical thoracoscopy in the management of pleural diseases 134
Baseline Exercise Tolerance and Perceived Dyspnea to Identify the Ideal Candidate to Pulmonary Rehabilitation: A Risk Chart in COPD Patients 134
Persisting exercise ventilatory inefficiency in subjects recovering from COVID-19. Longitudinal data analysis 34 months post-discharge 133
Asymptomatic peripheral artery disease can limit maximal exercise capacity in chronic obstructive pulmonary disease patients regardless of airflow obstruction and lung hyperinflation 130
Age is a determinant of short-term mortality in patients hospitalized for an acute exacerbation of COPD 130
Exercise ventilatory inefficiency may be a relevant CPET-feature in COVID-19 survivors 130
Clinical features and outcomes of elderly hospitalised patients with chronic obstructive pulmonary disease, heart failure or both 128
The Caliber of Segmental and Subsegmental Vessels in COVID-19 Pneumonia Is Enlarged: A Distinctive Feature in Comparison with Other Forms of Inflammatory and Thromboembolic Diseases 128
Short-term efficacy of upper-extremity exercise training in patients with chronic airway obstruction: A systematic review 128
Assessment of severity of ICU-acquired pneumonia and association with etiology 128
A Practical Approach to Pneumothorax Management 126
Are interstitial lung abnormalities associated with COPD? A nested case–control study 126
Relevance of Smoking Habit in Severe Asthma Patients: Evidence from the Severe Asthma Network in Italy (SANI) Registry 125
Anthropometry in Special and Selective Conditions and Circumstances: Anthropometry as Measure of Risk in COPD Patients 123
Activity and analysis of costs in a dedicated weaning centre 120
Association between persistent dyspnea and psychological distress in COVID-19 survivors. A cross-sectional evaluation at 11 months after hospitalization 119
Systemic Inflammatory Response and Outcomes in Community-Acquired Pneumonia Patients Categorized According to the Smoking Habit or Presence of Chronic Obstructive Pulmonary Disease 118
Clinical risk scores for the early prediction of severe outcomes in patients hospitalized for COVID-19 117
C-reactive protein at discharge, diabetes mellitus and ≥1 hospitalization during previous year predict early readmission in patients with acute exacerbation of chronic obstructive pulmonary disease 116
Feasibility and effectiveness of an educational program in Italian COPD patients undergoing rehabilitation 115
Association Between Rome Classification Among Hospitalized Patients With COPD Exacerbations and Short-Term and Intermediate-Term Outcomes 115
Effect of α1 Antitrypsin Deficiency on Lung Volume Decline in Severe Asthmatic Patients Undergoing Biologic Therapy 112
Endotracheal tubes for critically ill patients: An in vivo analysis of associated tracheal injury , mucociliary clearance, and sealing effi cacy 111
Management of severe acute exacerbations of COPD: an updated narrative review 110
Do Patients with Bronchiectasis Have an Increased Risk of Developing Lung Cancer? A Systematic Review 108
Exploring the efficacy and advancements of medical pleurodesis: a comprehensive review of current research 107
Endoscopic Technologies for Peripheral Pulmonary Lesions: From Diagnosis to Therapy 106
Aetiological diagnosis in new adult outpatients with bronchiectasis:role of predictors derived from real life experience 105
Reducing Hospital Readmissions in Chronic Obstructive Pulmonary Disease Patients: Current Treatments and Preventive Strategies 105
Factors associated with risk of death in hospitalized patients for exacerbation of chronic obstructive pulmonary disease: an updated scoping review 103
Endobronchial ultrasound: a pictorial essay 103
Effects of unsupported upper extremity exercise training in patients with COPD: A randomized clinical trial 103
Cough, a vital reflex. mechanisms, determinants and measurements 102
Relationships between emphysema and airways metrics at High-Resolution Computed Tomography (HRCT) and ventilatory response to exercise in mild to moderate COPD patients 102
Inhaled corticosteroids do not influence the early inflammatory response and clinical presentation of hospitalized subjects with COPD exacerbation 100
Effectiveness of erdosteine in elderly patients with bronchiectasis and hypersecretion: A 15-day, prospective, parallel, open-label, pilot study 100
Transthoracic Echocardiography and Chest Computed Tomography Arteriography in Patients with Acute Pulmonary Embolism: A Two-Year Follow-Up Study 99
Impact of bronchiectasis on outcomes of hospitalized patients with acute exacerbation of chronic obstructive pulmonary disease: A propensity matched analysis 98
Effects of a walking aid in COPD patients receiving oxygen therapy 98
Pneumonic versus Nonpneumonic Exacerbations of Chronic Obstructive Pulmonary Disease 98
Autonomic nervous system alterations in patients with mild-to-moderate asthma: do not forget airflow obstruction! a lesson from COPD 97
Cost-effectiveness of NIV applied to chronic respiratory failure 96
Prevalence of Depression in Sarcoidosis: a comparison with asthmatic and healthy controls 96
Predicting walking-induced oxygen desaturations in COPD patients: A statistical model 96
Use of non-invasive respiratory supports in high-intensity internal medicine setting during the first two waves of the COVID-19 pandemic emergency in Italy: a multicenter, real-life experience 96
The Role of Medical Thoracoscopy with Talc Poudrage in Spontaneous, Iatrogenic, and Traumatic Pneumothorax: A Prolonged Experience of a Tertiary Care Center 95
Rehabilitation and supportive therapy in elderly patients with chronic obstructive pulmonary disease 95
COPD and the metabolic syndrome: An intriguing association 95
Reply to "Mepolizumab in patients with eosinophilic granulomatosis with polyangiitis in remission: What is the right dose?" 94
Clinical variables predicting the risk of a hospital stay for longer than 7 days in patients with severe acute exacerbations of chronic obstructive pulmonary disease: a prospective study 94
Efficacy of standard rehabilitation in COPD outpatients with comorbidities 94
Rehabilitation in COPD patients admitted for exacerbation 94
Minimum Clinically Important Difference in 30-s Sit-to-Stand Test After Pulmonary Rehabilitation in Subjects With COPD 93
Inhaled beclometasone dipropionate/formoterol fumarate extrafine fixed combination for the treatment of asthma 93
Prevalence of Small-Airway Dysfunction among COPD Patients with Different GOLD Stages and Its Role in the Impact of Disease 93
Long-term weight loss and maintenance in morbidly obese individuals with obstructive sleep apnea 92
Learning impact of education during pulmonary rehabilitation program. An observational short-term cohort study 92
Home non-invasive mechanical ventilation and long-term oxygen therapy in stable hypercapnic chronic obstructive pulmonary disease patients: Comparison of costs 91
Home-centred physical fitness programme in morbidly obese individuals: A randomized controlled trial 90
Respiratory muscles training in COPD patients 89
Energy expenditure at rest and during walking in patients with chronic respiratory failure: a prospective two-phase case-control study 89
Postoperative Lung Function Advantages in Pulmonary Segmentectomy for Early‐Stage Lung Cancer 88
Pleuritis with pleural effusion due to a Bacillus megaterium infection 87
Systemic inflammatory pattern of patients with community-acquired pneumonia with and without COPD 87
Subjective sleep quality during average volume assured pressure support (AVAPS) ventilation in patients with hypercapnic COPD: A physiological pilot study 87
Readmission for acute exacerbation within 30 days of discharge is associated with a subsequent progressive increase in mortality risk in COPD patients: A long-Term observational study 87
Measures of dyspnea in pulmonary rehabilitation 86
Minimally Invasive Sampling of Mediastinal Lesions 86
Efficacy and Safety of Reparixin in Patients with Severe COVID-19 Pneumonia: A Phase 3, Randomized, Double-Blind Placebo-Controlled Study 85
Impact of the visceral adipose tissue on bone quality in patients with untreated mild-to-severe obstructive sleep apnea 85
Totale 13.256
Categoria #
all - tutte 66.733
article - articoli 64.815
book - libri 0
conference - conferenze 454
curatela - curatele 0
other - altro 300
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.164
Totale 133.466


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022417 0 0 0 22 13 20 6 74 30 26 88 138
2022/20231.583 132 115 230 246 130 380 12 104 140 21 42 31
2023/20241.002 47 73 139 141 63 126 48 92 10 40 127 96
2024/20252.767 196 103 79 420 131 126 108 152 431 172 265 584
2025/20269.202 586 365 1.434 1.334 2.026 540 777 548 685 436 199 272
2026/20271.579 132 279 258 910 0 0 0 0 0 0 0 0
Totale 17.255